NCT01500096View on ClinicalTrials.gov

American Ginseng to Improve HIV-Associated Fatigue: A Randomized, Placebo-Controlled, Parallel Design, Multiple-Dose Clinical Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
HIV/AIDS-associated Fatigue
Interventions
DRUG

American ginseng

American ginseng 1000 mg/day and 3000 mg/day will be evaluated in the intervention arms for this study. Participants will be randomized to American ginseng 1000 or 3000 mg/day capsules taken daily for four weeks.

DIETARY_SUPPLEMENT

Placebo for American ginseng

"Placebo for American ginseng 1000 mg/day and 3000 mg/day will be evaluated in the control arms for this study. Participants will be randomized to placebo for American ginseng 1000 or 3000 mg/day capsules taken daily for four weeks.~Arms: Placebo for American ginseng 1000 mg/day, Placebo for American ginseng 3000 mg/day"

Trial Locations (1)

21205

The Johns Hopkins University, Baltimore

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

Johns Hopkins University

OTHER

NCT01500096 - American Ginseng to Improve HIV-Associated Fatigue: A Randomized, Placebo-Controlled, Parallel Design, Multiple-Dose Clinical Trial | Biotech Hunter | Biotech Hunter